CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Open-market buy President & CEO bought 10,000 shares at an average $0.88 ($8,797)
- 4 Open-market buy Director bought 10,000 shares at an average $0.88 ($8,776)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B2 Offering Prospectus
- 424B2 Offering Prospectus
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- 4 Option exercise President and CEO acquired 5,995 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- RW Other RW
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B2 Offering Prospectus
- 8-K Event Regulation FD disclosure
- CT ORDER Other Confidential Order
Page 19 of 50 · 983 filings